Skip to content
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyInterventionalTrial registry record – peer review not applicable

Interventional Study in Individuals with Multiple Sclerosis

An interventional study was planned with 15 participants diagnosed with Multiple Sclerosis or Fibromyalgia, to compare active full-body stimulation against sham stimulation. The primary endpoint was the Berg Balance Scale. No results have been posted yet.

Most relevant to
—
This plain-English summary was written by AI from a trial registry record and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Human efficacy
Not established from this source
Mechanism
Not reported
Evidence strength
No results yet
Outcome
Not reported

Why it matters

This research aims to evaluate the effects of stimulation on balance in individuals with MS, potentially informing future therapies. However, the lack of results means we can't determine if this intervention was effective.

What this does not prove

The study is still ongoing with no findings reported and endpoints not established. Therefore, its implications remain unknown.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Interventional
Participants / samples
15 · planned enrolment
Randomised
Yes
Controlled
Yes
Primary endpoint met
Not reported
Relevant MS type
All
Publication date
Not reported
Evidence reviewed
Trial registry record
Regulatory approval
Not reported
Research areas
Not classified
Biological target
Not reported
Pathway
Not reported
Population
Individuals with a diagnosis of Multiple Sclerosis or Fibromyalgia; ages from 18 Years to 75 Years
Size of effect
Not reported
Secondary endpoints
Not reported
MRI endpoints
Not reported
Biomarkers
Not reported
Safety
Not reported

Original sources

Supporting passages (15)
study phasePhase: Not applicable
study designStudy type: Interventional
subjectsParticipants: people; ages from 18 Years to 75 Years; sex All
sample sizeEnrollment: 15 participants (estimated)
randomizedAllocation: Randomized
controlledArm types: Experimental; Sham comparator
relevant ms typesConditions: Multiple Sclerosis; Fibromyalgia; Neurologic Disorder; Neuromuscular Disorders
primary endpointPrimary endpoints: Berg Balance Scale
populationhaving a definite diagnosis for at least one month\n 2.
findingsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
limitationsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
peer reviewedTrial registry record.
interventionInterventions: Active full-body stimulation; Sham full-body stimulation
follow upFollow-up: Baseline 1 (prior to Arm 1)- initial visit, Endpoint 1 (after Arm 1)- at ~2 weeks, Baseline 2 (after 2 week washout and before Arm 2)- at ~4 weeks, Endpoint 2 (after Arm 2)- at ~6 weeks, Follow-Up (2 weeks after Endpoint 2)- at ~8 weeks
sample size basisEnrollment: 15 participants (estimated)

AI assessment, not yet reviewed by a person · version 3 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.